Clinical trial
A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR™ 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels
NCT05946629 is registered in ClinicalTrials.gov with M.A. Med Alliance S.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR™ 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels
- Lead sponsor
- M.A. Med Alliance S.A.
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- October 20, 2023
- Completion date
- September 30, 2031
- Enrollment
- 960 (estimated)
- Sites
- 70
Conditions
As the registry lists them; a condition with its own page is linked.